However, in order to understand the mechanism of action of the drug it is essential not only to focus studies on the effects of PTK787 on the tumor cell environment/vasculature but also on the tumor cells themselves, which were also shown to express VEGFR family members (2). The gene discussed is KDR; the disease is neoplasm.